Seer (SEER) Share-based Compensation (2020 - 2026)
Seer (SEER) recorded quarterly Share-based Compensation of $2.1 million in Q1 2026, down 35.27% quarter-over-quarter from $3.3 million in Q4 2025, and down 54.39% on a YoY basis from $4.7 million in Q1 2025.
Seer (SEER) Share-based Compensation (2020 - 2026) Analysis & Trends
Seer's Share-based Compensation history runs 7 years deep, the most recent figure standing at $2.1 million for Q1 2026.
- In Q1 2026, Share-based Compensation fell 54.39% year-over-year to $2.1 million; the TTM figure through Mar 2026 stood at $12.9 million (down 39.68% YoY), while the FY2025 annual figure was $15.4 million, down 45.35% from the prior year.
- Share-based Compensation was $2.1 million for Q1 2026 at Seer, down from $3.3 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $9.8 million in Q2 2023 to a low of $2.1 million in Q1 2026.
- Historically, Share-based Compensation has averaged $6.5 million across 5 years, with a median of $7.6 million in 2023.
- The sharpest annual moves came in 2022 and 2024: Share-based Compensation surged 33.7% in 2022, then sank 67.17% in 2024.
- A 5-year view of Share-based Compensation shows it stood at $8.2 million in 2022, then dropped by 6.69% to $7.6 million in 2023, then tumbled by 67.17% to $2.5 million in 2024, then jumped by 31.44% to $3.3 million in 2025, then sank by 35.27% to $2.1 million in 2026.
- The last three Share-based Compensation figures came in at $2.1 million (Q1 2026), $3.3 million (Q4 2025), and $3.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 305,000.00 |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 166.40 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 26.47 Mn |
| 10 | Seer | 95.75 Mn | 95.75 Mn | 982,000.00 | 2.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.13 Mn |
| Mar 31, 2026 | 2.13 Mn |
| Dec 31, 2025 | 3.29 Mn |
| Dec 31, 2025 | 3.29 Mn |
| Sep 30, 2025 | 3.59 Mn |
| Sep 30, 2025 | 3.59 Mn |
| Jun 30, 2025 | 3.87 Mn |
| Jun 30, 2025 | 3.87 Mn |
| Mar 31, 2025 | 4.66 Mn |
| Mar 31, 2025 | 4.66 Mn |
| Dec 31, 2024 | 2.50 Mn |
| Dec 31, 2024 | 2.50 Mn |
| Sep 30, 2024 | 6.52 Mn |
| Sep 30, 2024 | 6.52 Mn |
| Jun 30, 2024 | 7.67 Mn |
| Jun 30, 2024 | 7.67 Mn |
| Mar 31, 2024 | 7.58 Mn |
| Mar 31, 2024 | 7.58 Mn |
| Dec 31, 2023 | 7.61 Mn |
| Dec 31, 2023 | 7.61 Mn |